SCHEMBL6896045

SCHEMBL6896045

COCCCNC(c1ccccc1)[C@H](N)[C@@H](C)O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
HPGD P15428 3/20 0.48
SCN8A Q9UQD0 1/20 0.41
POLB P06746 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPK1 P28482 1/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ANPEP P15144 1/20 0.37
ADRA2A P08913 1/20 0.37
ADRA2C P18825 1/20 0.37
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6895074 0.92 HPGD (0.44) ALDH1A1HPGDTDP1KDM4ELMNA
SCHEMBL6890858 0.83 SIGMAR1 (0.50) ALDH1A1LMNAGAANPSR1
SCHEMBL6887458 0.82 SIGMAR1 (0.51) KMT2A
SCHEMBL6887766 0.81 ALDH1A1 (0.33) ALDH1A1HPGDPOLBKDM4EKMT2A
SCHEMBL6894568 0.80 CYP3A4 (0.44) ALDH1A1KDM4ELMNAKMT2ASMN1; SMN2
SCHEMBL6890899 0.80 AOC3 (0.36) ALDH1A1KDM4ELMNAKMT2ASMN1; SMN2
SCHEMBL6889436 0.78 SIGMAR1 (0.49) ALDH1A1POLBLMNASMN1; SMN2ANPEP
SCHEMBL6891363 0.76 KMT2A (0.55) ALDH1A1TDP1KDM4EKMT2AGAA
SCHEMBL6895263 0.76 KDM4E (0.43) ALDH1A1KDM4ELMNAANPEPADRA2A
SCHEMBL6894924 0.76 KDM4E (0.43) ALDH1A1KDM4ELMNAANPEPADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed